1. Contemporary outcomes with percutaneous vascular interventions for peripheral critical limb ischemia in those with and without poly-vascular disease
- Author
-
Kahn Munir, John E. Rectenwald, Venkat Krishnamurthy, Hitinder S. Gurm, Ash Mansour, Paul M. Grossman, Katherine A. Gallagher, Dave A Share, Peter K. Henke, Jonathan L. Eliason, Sachinder Singh Hans, and Guillermo A. Escobar
- Subjects
Adult ,Male ,medicine.medical_specialty ,Percutaneous ,Anemia ,medicine.medical_treatment ,Amputation, Surgical ,Coronary artery disease ,Peripheral Arterial Disease ,Ischemia ,Risk Factors ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Ankle Brachial Index ,Prospective Studies ,Vascular Patency ,Aged ,Aged, 80 and over ,Vascular disease ,business.industry ,Extremities ,Critical limb ischemia ,Middle Aged ,Limb Salvage ,medicine.disease ,Surgery ,body regions ,Treatment Outcome ,Amputation ,Heart failure ,Cardiology ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business - Abstract
Given the very ill nature of patients with critical limb ischemia (CLI), the use of percutaneous vascular interventions (PVIs) for limb salvage may or may not be efficacious; in particular, for those with polyvascular arterial disease. Herein, we reviewed large, multi-institutional outcomes of PVI in polyvascular and peripheral arterial disease (PAD) patients with CLI. An 18-hospital consortium collected prospective data on patients undergoing endovascular interventions for PAD with 6-month follow-up from January 2008 to December 2011. The patient cohort included 4459 patients with CLI; of those, 3141 patients had polyvascular (coronary artery disease, cerebrovascular disease and PAD) disease, whereas 1318 patients suffered from only PAD. All patients were elderly and with significant comorbidities. The mean ankle–brachial index (ABI) was 0.44 and was not different between those with and without polyvascular disease. Polyvascular patients had more femoropopliteal and infra-inguinal interventions and less aortoiliac interventions than PAD patients. Pre- and post-procedural cardioprotective medication use was less in the PAD patients as compared with polyvascular patients. Vascular complications requiring surgery were higher in PAD patients whereas other access complications were similar between groups. At 6-month follow-up, death was more common in the polyvascular group (6.7% vs 4.1%, p
- Published
- 2014
- Full Text
- View/download PDF